Real-World Efficacy of the Dabrafenib-Trametinib (D-T) Combination in Braf V600e-Mutated Metastatic Non-Small Cell Lung Cancer (nsclc): Results from the Ifct-2004 Blade Cohort
LUNG CANCER（2025）
关键词
Non-small-cell lung cancer,BRAF mutation,Targeted therapy,Dabrafenib-trametinib combination,Real-world evidence
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要